Clinical trials
Participation clinical trials
Below are recruiting participation clinical trials, each written for real people, not researchers. We’re tracking 2,211 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07587788RecruitingPhase 2
RBD5044 Treatment for High Triglycerides in China
This study tests a new drug called RBD5044 to lower triglycerides (a type of fat in your blood) in people with elevated levels. If your triglycerides are moderately high and you're on standard cholesterol medications, this trial may help you manage your condition better.
Daqing, HeilongjiangAges 18–80 - NCT07588022Recruiting
How Your Body Reacts to Jägermeister Mixed with Energy Drinks
This study examines what happens to your heart, blood pressure, and overall health when you drink Jägermeister (a digestif liqueur) mixed with energy drinks. Researchers want to understand the physical effects of combining alcohol and high-caffeine beverages in healthy young adults.
BarcelonaAges 18–45 - NCT07588100RecruitingPhase 1
Safety study of RO7663498 eye injection for diabetic retinopathy
This is an early-stage safety study testing a new medicine injected directly into the eye to treat diabetic retinopathy (damage to blood vessels in the retina caused by diabetes). The study checks if the medicine is safe and how the body processes it.
Glendale, CaliforniaAges 18 years+ - NCT07589114Recruiting
Sleep technology to improve mood and well-being
This study tests a technology designed to enhance REM sleep (the stage where you dream) to help improve your mood, emotions, and overall quality of life. Researchers want to see if better sleep quality can boost your well-being.
Târgu Mureş, Mureș CountyAges 18 years+ - NCT07589205RecruitingPhase 1
Testing IBI3028 for Advanced Solid Tumors
This early-stage trial tests a new drug called IBI3028 in people with advanced cancers that cannot be removed by surgery or have spread. The study aims to find the right dose and understand how the drug works in your body.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07589608RecruitingPhase 2
Weight Loss Study With Two New Injectable Medications
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
Chandler, ArizonaAges 18–75 - NCT07590102RecruitingPhase 1
How Body Works With a New Drug and Two Other Medicines
This study tests how a new experimental drug (BGB-58067) moves through your body and how two common medications affect that process. Researchers need healthy volunteers to understand if these drug interactions are safe.
AdelaideAges 18–65 - NCT07592572RecruitingPhase 1
How Itraconazole Affects a New Study Drug in Healthy Adults
This study tests how a common antifungal medication (itraconazole) changes how the body processes an experimental drug (LY4395089). Researchers enroll healthy volunteers to understand if these two drugs interact safely together.
Lenexa, KansasAges 18–64 - NCT07593859Recruiting
Brain Stimulation Research Study for Healthy Adults
This study tests a new non-invasive brain stimulation technique called transcranial temporal interference stimulation. Researchers want to understand how to make it work better and safer in humans.
Boston, MassachusettsAges 18–65 - NCT07598747Recruiting
Blood test to detect cancer early using DNA analysis
This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.
SeoulAges 19 years+ - NCT07599670RecruitingPhase 1/Phase 2
Safety study of ABBV-1758 injection for Alzheimer's disease
This early-stage trial tests whether ABBV-1758, a new drug given by injection, is safe and effective for people with Alzheimer's disease. The drug targets amyloid, a protein that builds up in the brains of people with Alzheimer's.
Irvine, CaliforniaAges 50–90 - NCT07599761RecruitingPhase 1
Study of How Itraconazole Affects ABBV-722 in Healthy Adults
This early-stage study tests how a common antifungal medicine (itraconazole) affects how the body processes an experimental drug called ABBV-722. Researchers enroll only healthy people to safely measure these interactions.
Grayslake, IllinoisAges 18–65 - NCT07602088Recruiting
Real-world Study of Two Cancer Drugs for Chronic Lymphocytic Leukemia
This study follows patients with chronic lymphocytic leukemia (CLL)—a blood cancer—who are starting treatment with two drugs called ibrutinib and venetoclax together for a set period of time. Researchers want to understand how well this treatment works and how it affects patients' daily lives in real-world settings, rather than in a controlled lab environment.
BucharestAges 18 years+ - NCT07604558RecruitingPhase 1
Safety study of bretisilocin injection in healthy adults
This is an early-stage safety study testing how a new injection called bretisilocin moves through your body and what side effects it may cause. Researchers are enrolling healthy adults from different ethnic backgrounds to understand if the drug is safe.
Los Alamitos, CaliforniaAges 18–65 - NCT07606105RecruitingPhase 1
Iron Injection Safety and Effectiveness Study in Healthy Adults
This study tests a new iron injection medication in healthy people to ensure it works the same way as a reference version. Participants will receive the injection while fasting and undergo blood tests to measure how the body processes the iron.
JinanAges 18–55 - NCT07606573Recruiting
Brain stimulation study testing sensory activation
This research study tests a non-invasive brain stimulation method to see how it activates your senses and nervous system. You'll receive gentle electrical stimulation while researchers record your brain activity, which may help future treatments.
Minneapolis, MinnesotaAges 18–65 - NCT07607483RecruitingPhase 1
Safety Study of LY4065967 in Healthy Adults
This is an early-stage safety study testing a new experimental drug (LY4065967) in people with no major health conditions. Researchers will monitor how your body tolerates the drug and what happens to it in your system.
Daytona Beach, FloridaAges 18–55 - NCT07607587RecruitingPhase 1
Testing a new weight-loss drug for people who couldn't tolerate GLP-1 shots
This study tests a new injectable medication called cagrilintide for people with obesity who had to stop GLP-1 drugs (like Ozempic or Wegovy) because of stomach problems. The goal is to see if cagrilintide causes fewer stomach side effects while still helping with weight.
Walnut Creek, CaliforniaAges 18 years+ - NCT07608432RecruitingPhase 3
Testing a New DMD Treatment Given Every 4 Weeks
This study tests whether a new medicine called zeleciment rostudirsen can help ambulatory (walking) males with Duchenne muscular dystrophy (DMD). The medicine is given as an intravenous infusion (through a vein) every 4 weeks and works by helping the body produce a protective muscle protein.
Hillsborough, North CarolinaAges 4–18 - NCT07608705RecruitingPhase 1
How HRS-1301 Affects Body Processing of Two Common Drugs
This study tests how a new drug called HRS-1301 changes the way your body processes two common medications: midazolam (a sedative) and atorvastatin (a cholesterol drug). Healthy volunteers help researchers understand drug safety and interactions before testing in patients with illness.
Jinan, ShandongAges 18–55 - NCT07610005RecruitingPhase 1
Varegacestat dosing study in healthy adults
This early-stage study tests how the body absorbs and processes a new drug called varegacestat in healthy people. Researchers will compare different ways of giving the drug to understand how well it works.
Tempe, ArizonaAges 18–55 - NCT07610850Recruiting
Brain-controlled stimulation to improve arm and leg movement after stroke
This trial tests a new brain-controlled device that sends electrical signals to your spinal cord to help restore arm and leg movement after a stroke. If you had a stroke at least 9 months ago and have weakness on one side of your body, this may help you regain function.
Lausanne, Canton of VaudAges 18–70 - NCT07612020RecruitingPhase 1
How Well a New Injection Works Compared to IV
This study tests a new medicine called empasiprubart that can be injected under the skin using an autoinjector (like an EpiPen). Researchers want to see how much of the medicine gets into your bloodstream and whether the injection works as well as an IV infusion. You'll be a healthy volunteer helping them understand if this new delivery method is effective.
Mount Royal, QuebecAges 18–65 - NCT07612176RecruitingPhase 1
Testing NEOK001 drug for advanced solid tumors
This study tests a new cancer drug called NEOK001 that targets two proteins (B7-H3 and ROR1) found on certain tumor cells. The drug combines a cancer-fighting molecule with a toxic payload to kill cancer cells while sparing healthy tissue.
New York, New YorkAges 18 years+
Hear when a new Participation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for participation?
- Yes. Clin2 currently lists 2,211 recruiting participation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a participation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a participation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.